Dexcom (DXCM) Common Equity (2010 - 2026)
Dexcom's Common Equity came in at $2.54 billion for Q3 2026, down 7.0% from $2.73 billion a year earlier and down 3.3% from the prior quarter.
Powered by 
Analysis
Dexcom (DXCM) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Dexcom's Common Equity was $2.75 billion, up 30.6% from FY2024.
- Common Equity carries a five-year compound annual growth rate of 12.1% (FY2020 to FY2025).
- Going back by year, Common Equity was $2.1 billion in FY2024 (+1.6%), $2.07 billion in FY2023 (-3.0%), $2.13 billion in FY2022 (+4.4%) and $2.04 billion in FY2021 (+31.6%).
- The Q3 2026 figure represents the lowest quarterly Common Equity since Q1 2025.
- Year-over-year, Common Equity increased in seven of the last eight quarters, with growth averaging 12.7%.
- The fastest year-over-year change in Common Equity over five years came in Q3 2025 (growth of 37.8%), and the weakest in Q3 2024 (a decline of 12.7%).
- Business Quant data shows DXCM's Common Equity at $2.62 billion (Q2 2026), $2.96 billion (Q1 2026) and $2.75 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 265.71 Bn | 242.23 Bn | 5.13 Bn | 54.77 Bn |
| 2 | Abbott Laboratories | 189.37 Bn | 163.23 Bn | 7.39 Bn | 51.62 Bn |
| 3 | Danaher | 164.78 Bn | 144.43 Bn | 3.84 Bn | 53.63 Bn |
| 4 | Intuitive Surgical | 157.85 Bn | 138.13 Bn | 2.08 Bn | 16.12 Bn |
| 5 | Medtronic | 129.66 Bn | 94.91 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 121.82 Bn | 108.01 Bn | 4.25 Bn | 23.46 Bn |
| 7 | Boston Scientific | 63.42 Bn | 58.86 Bn | 3.43 Bn | 25.87 Bn |
| 8 | Edwards Lifesciences | 59.49 Bn | 42.69 Bn | 1.35 Bn | 10.96 Bn |
| 9 | Becton Dickinson | 58.38 Bn | 55.53 Bn | 2.32 Bn | 24.42 Bn |
| 10 | Dexcom | 29.96 Bn | 21.78 Bn | 864.40 Mn | 2.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.54 Bn |
| Jun 30, 2026 | 2.62 Bn |
| Mar 31, 2026 | 2.96 Bn |
| Dec 31, 2025 | 2.75 Bn |
| Sep 30, 2025 | 2.73 Bn |
| Jun 30, 2025 | 2.57 Bn |
| Mar 31, 2025 | 2.27 Bn |
| Dec 31, 2024 | 2.10 Bn |
| Sep 30, 2024 | 1.98 Bn |
| Jun 30, 2024 | 2.43 Bn |
| Mar 31, 2024 | 2.25 Bn |
| Dec 31, 2023 | 2.07 Bn |
| Sep 30, 2023 | 2.27 Bn |
| Jun 30, 2023 | 2.10 Bn |
| Mar 31, 2023 | 2.23 Bn |
| Dec 31, 2022 | 2.13 Bn |
| Sep 30, 2022 | 1.82 Bn |
| Jun 30, 2022 | 2.26 Bn |
| Mar 31, 2022 | 2.19 Bn |
| Dec 31, 2021 | 2.04 Bn |
API Access
Dexcom Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=DXCM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "DXCM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=DXCM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();